| miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 NMA White, HWZ Khella, J Grigull, S Adzovic, YM Youssef, RJ Honey, ... British journal of cancer 105 (11), 1741-1749, 2011 | 195 | 2011 |
| miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma HWZ Khella, M Bakhet, G Allo, MAS Jewett, AH Girgis, A Latif, H Girgis, ... Carcinogenesis 34 (10), 2231-2239, 2013 | 191 | 2013 |
| The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma H Faragalla, YM Youssef, A Scorilas, B Khalil, NMA White, ... The Journal of Molecular Diagnostics 14 (4), 385-392, 2012 | 132 | 2012 |
| Exosomal microRNAs are diagnostic biomarkers and can mediate cell–cell communication in renal cell carcinoma H Butz, R Nofech-Mozes, Q Ding, HWZ Khella, PM Szabó, M Jewett, ... European urology focus 2 (2), 210-218, 2016 | 131 | 2016 |
| Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma AH Girgis, VV Iakovlev, B Beheshti, J Bayani, JA Squire, A Bui, ... Cancer research 72 (20), 5273-5284, 2012 | 107 | 2012 |
| miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 H Butz, PM Szabó, HWZ Khella, R Nofech-Mozes, A Patocs, GM Yousef Oncotarget 6 (14), 12543, 2015 | 86 | 2015 |
| miR-221/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma HWZ Khella, H Butz, Q Ding, F Rotondo, KR Evans, P Kupchak, ... Molecular therapy 23 (11), 1748-1758, 2015 | 85 | 2015 |
| Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses HWZ Khella, NMA White, H Faragalla, M Gabril, M Boazak, D Dorian, ... Tumor Biology 33, 131-140, 2012 | 72 | 2012 |
| Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma HWZ Khella, A Scorilas, R Mozes, L Mirham, E Lianidou, SN Krylov, ... The American Journal of Pathology 185 (3), 693-703, 2015 | 71 | 2015 |
| Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma NP Damayanti, JA Budka, HWZ Khella, MW Ferris, SY Ku, E Kauffman, ... Clinical Cancer Research 24 (23), 5977-5989, 2018 | 69 | 2018 |
| miR-210 is a prognostic marker in clear cell renal cell carcinoma S Samaan, HWZ Khella, A Girgis, A Scorilas, E Lianidou, M Gabril, ... The Journal of Molecular Diagnostics 17 (2), 136-144, 2015 | 69 | 2015 |
| MicroRNAs in kidney disease: an emerging understanding HWZ Khella, M Bakhet, Z Lichner, AD Romaschin, MAS Jewett, ... American journal of kidney diseases 61 (5), 798-808, 2013 | 60 | 2013 |
| Micro RNA‐194 is a marker for good prognosis in clear cell renal cell carcinoma R Nofech‐Mozes, HWZ Khella, A Scorilas, L Youssef, SN Krylov, ... Cancer Medicine 5 (4), 656-664, 2016 | 47 | 2016 |
| miR-10b is a prognostic marker in clear cell renal cell carcinoma HWZ Khella, N Daniel, L Youssef, A Scorilas, R Nofech-Mozes, L Mirham, ... Journal of Clinical Pathology 70 (10), 854-859, 2017 | 33 | 2017 |
| Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer KG Sidiropoulos, NMA White, A Bui, Q Ding, P Boulos, G Pampalakis, ... Oncoscience 1 (11), 709, 2014 | 33 | 2014 |
| The miR-200 family as prognostic markers in clear cell renal cell carcinoma R Saleeb, SS Kim, Q Ding, A Scorilas, S Lin, HWZ Khella, C Boulos, ... Urologic Oncology: Seminars and Original Investigations 37 (12), 955-963, 2019 | 30 | 2019 |
| A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization A Di Meo, R Saleeb, SJ Wala, HW Khella, Q Ding, H Zhai, K Krishan, ... Oncotarget 9 (2), 2092, 2018 | 25 | 2018 |
| Translational research: empowering the role of pathologists and cytopathologists HWZ Khella, GM Yousef Cancer Cytopathology 126 (10), 831-838, 2018 | 6 | 2018 |
| Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations MH ElSayed, HM Atif, MA Eladl, SM Elaidy, AMN Helaly, FA Hisham, ... Biomedicine & Pharmacotherapy 164, 114917, 2023 | 5 | 2023 |
| Supression of tumor progression and metastasis in renal cell carcinoma by miR-192, miR-194, and miR-215. HWZ Khella, M Bakhet, G Allo, MAS Jewett, A Girgis, GA Bjarnason, ... Journal of Clinical Oncology 31 (6_suppl), 385-385, 2013 | 1 | 2013 |
